David Lang
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Cancer survivorship and care
- Lung Cancer Research Studies
-
- IgG4-Related and Inflammatory Diseases
Papers in
-
- Lung Cancer Treatments and Mutations 7
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 7
- Lung Cancer Diagnosis and Treatment 4
- Medical Imaging and Pathology Studies 2
- Oncology 12
- Cancer Immunotherapy and Biomarkers 8
- Lung Cancer Research Studies 3
- Co-authors
- Bernd Lamprecht (22 shared papers)Herwig Pieringer (4 shared papers)Jochen Zwerina (1 shared paper)Karen Murphy (1 shared paper)Joseph A. Roscoe (1 shared paper)Karen M. Mustian (1 shared paper)Jeffrey A. Katula (1 shared paper)Diane L. Gill (1 shared paper)
- Journals
- Cancers (2 papers)Journal of Clinical Medicine (2 papers)ESMO Open (1 paper)Lung (1 paper)Frontiers in Medicine (1 paper)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
David Lang
27 papers receiving 455 citations
Peers
Comparison fields: 5 of 71
- Oncology 170
- Rheumatology 62
- Pulmonary and Respiratory Medicine 117
- Complementary and alternative medicine 22
- Physical Therapy, Sports Therapy and Rehabilitation 8
Countries citing papers authored by David Lang
This map shows the geographic impact of David Lang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Lang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Lang more than expected).
Fields of papers citing papers by David Lang
This network shows the impact of papers produced by David Lang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Lang. The network helps show where David Lang may publish in the future.
Co-authors
The 25 scholars most cited alongside David Lang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 124 | |
| 2 | 2016 | 65 | |
| 3 | 2019 | 47 | |
| 4 | 2018 | 42 | |
| 5 | 2019 | 36 | |
| 6 | 2020 | 32 | |
| 7 | 2021 | 17 | |
| 8 | 2019 | 13 | |
| 9 | 2016 | 12 | |
| 10 | 2023 | 10 | |
| 11 | 1993 | 10 | |
| 12 | 2024 | 10 | |
| 13 | 2021 | 10 | |
| 14 | 2017 | 7 | |
| 15 | 2020 | 6 | |
| 16 | 2021 | 5 | |
| 17 | 2022 | 4 | |
| 18 | 2020 | 4 | |
| 19 | 2024 | 3 | |
| 20 | Control of post-extraction bacteraemias in the penicillin-hypersensitive patient. | 1972 | 3 |
About David Lang
David Lang is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Physiology, Surgery and Epidemiology, having authored 31 papers that have together received 471 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Lung Cancer Treatments and Mutations (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Lung Cancer Diagnosis and Treatment (4 papers), Lung Cancer Research Studies (3 papers), Sarcoidosis and Beryllium Toxicity Research (3 papers), Cancer Genomics and Diagnostics (2 papers) and Medical Imaging and Pathology Studies (2 papers). The work is most often cited by research in Oncology (170 citations), Rheumatology (62 citations), Pulmonary and Respiratory Medicine (117 citations), Complementary and alternative medicine (22 citations) and Physical Therapy, Sports Therapy and Rehabilitation (8 citations). David Lang has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Bernd Lamprecht, Herwig Pieringer, Jochen Zwerina, Karen Murphy, Joseph A. Roscoe, Karen M. Mustian, Jeffrey A. Katula, Diane L. Gill, Andreas Horner and Kaveh Akbari. Their work appears in journals such as Cancers, Journal of Clinical Medicine, ESMO Open, Lung and Frontiers in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.